by Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.) Scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) have identified a possible treatment for Alzheimer’s disease. Working together with a scientific team at the Rockefeller University in New York, the investigators have shown that treatment with the oral anticoagulant dabigatran delays the appearance of Alzheimer’s disease in mice. The results published today in the Journal of the American College...
Tag: <span>Alzheimer’s disease</span>
Post
Chemist discovers promising compound for a future drug against Alzheimer’s disease
by RUDN University Biochemists from RUDN University (Russia) and the University of Bari (Italy) report a group of compounds that can become a molecular scaffold for new drugs for Alzheimer’s disease. They have demonstrated that derivatives of 1,2,3,4,5,6-hexahydroazepino[4,3-b]indole, or HHAI, are effective inhibitors of acetylcholinesterase and butyrylcholinesterase—enzymes whose increased activity can worsen the condition in...
Post
Commonly used drug for Alzheimer’s disease doubles risk of hospitalization
CANADIAN MEDICAL ASSOCIATION JOURNAL A drug commonly used to manage symptoms of Alzheimer disease and other dementias — donepezil — is associated with a two-fold higher risk of hospital admission for rhabdomyolysis, a painful condition of muscle breakdown, compared with several other cholinesterase inhibitors, found a study in CMAJ (Canadian Medical Association Journal). Dementia is a growing problem, with almost 10 million newly diagnosed cases...
Post
Eye scan sheds new light on Alzheimer’s disease
by Centre for Eye Research Australia (CERA) New research by Australian scientists has demonstrated that a quick, non-invasive eye scan can identify changes in the retina that could be used to diagnose Alzheimer’s disease. In a world-first, the team led by Associate Professor Peter van Wijngaarden and Dr. Xavier Hadoux from the Centre for Eye...
Post
Is copper a cause of Alzheimer’s disease?
University of Houston researcher examines the link UNIVERSITY OF HOUSTON A University of Houston chemist is exploring the link between copper protein molecules in brain cells and neurodegenerative diseases like Alzheimer’s. “Scientists have studied Alzheimer’s disease for 100 years and still no one knows the cause,” said assistant professor of chemistry Tai-Yen Chen, who will...
Post
Alzheimer’s memory loss reversed by new head device using electromagnetic waves
Just released new results in the Journal of Alzheimer’s Disease indicate that in-home treatment with a bioengineered head device emitting electromagnetic waves reversed memory impairment of Alzheimer’s patients (AD) IOS PRESS Phoenix, AZ (September 17, 2019) – There is finally some encouraging news for the millions of Americans suffering from Alzheimer’s Disease. NeuroEM Therapeutics today announced findings...
Post
Low grip strength linked to impaired cognition, memory loss in older Americans
by Laura Bailey, University of Michigan For older Americans, poor hand grip may be a sign of impaired cognition and memory, a new study suggests. Researchers from the University of Michigan and North Dakota State University followed nearly 14,000 participants from the 2006 Health and Retirement Study, age 50 and older, for eight years. They...
Post
Could targeting variants of this gene help fight Alzheimer’s disease?
By Catharine Paddock PhD Fact checked by Carolyn Robertson Scientists have identified gene variants that appear able to alter the risk of Alzheimer’s disease by changing levels of a protein that is present in cerebrospinal fluid. In a recent Science Translational Medicinepaper, the international team describes how variants in the MS4A4A gene influence the risk...
Post
Eye-tracking tests may be key to predicting who will develop Alzheimer’s disease, study finds
by Loughborough University New research has found that it may be possible to predict if people with mild memory and thinking impairments will go onto develop Alzheimer’s disease using eye-tracking technology. Dr. Thom Wilcockson, of Loughborough University’s School of Sports, Exercise and Health Sciences, says he hopes the findings in the new paper he is...
Post
When Technology Remembers: Digital Health And Alzheimer’s Disease
The Medical Futurist Gradual memory loss, cognitive decline, wandering off to unknown places, being unable to dress in the morning: to live with dementia and Alzheimer’s disease might be a heart-wrenching burden for both patients and their loved ones. As the global population ages, and the number of individuals suffering from these conditions rises, digital...